Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.

Amy PeacockBriony LaranceMichael FarrellRose CairnsNicholas BuckleyLouisa Degenhardt

Published in: BMJ open (2018)

Ethics approval is not required for use of pharmaceutical sales data. Ethics approval has been obtained for use of national pharmaceutical opioid poisonings reported to PICs (LNR/16/SCHN/44) and for use of online marketplace data and interview data from people who inject drugs (HC12086). Key findings will be published mid-2018 in a peer-reviewed academic journal, and presented at various conferences and professional meetings.

Keyphrases

big data
electronic health record
study protocol
public health
randomized controlled trial
clinical trial
machine learning
drug administration
drug delivery
chronic pain
pain management
artificial intelligence
global health
deep learning
health insurance